MedTrace Logo

Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)

NCT06894823 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 16000

Last updated 2025-03-25

No results posted yet for this study

Summary

COESIT aims to establish a network of reference laboratories in the central-southern regions of Italy for the genetic and molecular characterization of tumors, with the goal of implementing precision and personalized oncology in clinical practice.

Conditions

Interventions

OTHER

Creation of a laboratory network

Creation of a laboratory network in Central-Southern Italy capable of performing complex genomic analyses.

OTHER

Mapping of genomic alterations

Mapping of genomic alterations aimed at precision medicine and personalized diagnostic and therapeutic approaches.

OTHER

Creation of a bioinformatics network among the participating institutions.

Creation of a bioinformatics network among the participating institutions.

OTHER

Development of a platform for the collection of clinicopathological and genetic-molecular data.

Development of a platform for the collection of clinicopathological and genetic-molecular data.

OTHER

Identification of prognostic and predictive factors for the implementation of precision oncology strategies based on genomic profiling.

Identification of prognostic and predictive factors for the implementation of precision oncology strategies based on genomic profiling.

Sponsors & Collaborators

  • National Cancer Institute, Naples

    lead OTHER

Principal Investigators

  • Antonella De Luca · Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-10
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06894823 on ClinicalTrials.gov